Back to Search
Start Over
A functional substitution in the L-aromatic amino acid decarboxylase enzyme worsens somatic symptoms via a serotonergic pathway.
- Source :
-
Annals of Neurology . Aug2019, Vol. 86 Issue 2, p168-180. 13p. - Publication Year :
- 2019
-
Abstract
- <bold>Objective: </bold>Heightened somatic symptoms are reported by a wide range of patients with chronic pain and have been associated with emotional distress and physical dysfunction. Despite their clinical significance, molecular mechanisms leading to their manifestation are not understood.<bold>Methods: </bold>We used an association study design based on a curated list of 3,295 single nucleotide polymorphisms mapped to 358 genes to test somatic symptoms reporting using the Pennebaker Inventory of Limbic Languidness questionnaire from a case-control cohort of orofacial pain (n = 1,607). A replication meta-analysis of 3 independent cohorts (n = 3,189) was followed by functional validation, including in silico molecular dynamics, in vitro enzyme assays, and measures of serotonin (5-HT) plasma concentration.<bold>Results: </bold>An association with the T allele of rs11575542 coding for an arginine to glutamine substitution in the L-aromatic amino acid decarboxylase (AADC) enzyme was replicated in a meta-analysis of 3 independent cohorts. In a combined meta-analysis of all cohorts, this association reached p = 6.43 × 10-8 . In silico studies demonstrated that this substitution dramatically reduces the conformational dynamics of AADC, potentially lowering its binding capacity to a cofactor. in vitro enzymatic assays showed that this substitution reduces the maximum kinetic velocity of AADC, hence lowering 5-HT levels. Finally, plasma samples from 90 subjects showed correlation between low 5-HT levels and heightened somatic symptoms.<bold>Interpretation: </bold>Using functional genomics approaches, we identified a polymorphism in the AADC enzyme that contributes to somatic symptoms through reduced levels of 5-HT. Our findings suggest a molecular mechanism underlying the pathophysiology of somatic symptoms and opens up new treatment options targeting the serotonergic system. ANN NEUROL 2019;86:168-180. [ABSTRACT FROM AUTHOR]
- Subjects :
- *SINGLE nucleotide polymorphisms
*GLUTAMINE
*FUNCTIONAL genomics
*AMINO acids
*MOLECULAR dynamics
*OROFACIAL pain
*ENZYMES
*PROTEINS
*RESEARCH
*RESEARCH methodology
*FACIAL pain
*SEROTONIN
*CASE-control method
*EVALUATION research
*MEDICAL cooperation
*CELLULAR signal transduction
*COMPARATIVE studies
*RESEARCH funding
*GENETIC techniques
*EPITHELIAL cells
*LONGITUDINAL method
Subjects
Details
- Language :
- English
- ISSN :
- 03645134
- Volume :
- 86
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Annals of Neurology
- Publication Type :
- Academic Journal
- Accession number :
- 137436314
- Full Text :
- https://doi.org/10.1002/ana.25521